ReviewMolecular medicine reports2026
Potential for anti‑angiogenic therapy targeting the receptor for advanced glycation end products/VEGF axis in ulcerative colitis (Review).
Chen Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.